west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "抗癫痫药物" 40 results
  • 2023美国癫痫学会年会荟萃报道(一)

    美国癫痫学会(American Epilepsy Society,AES)年会是每年一度国际癫痫学界及工业界最受关注的会议。本年度的AES年会自2023年12月1日在奥兰多召开,为期5天,讨论了目前最受关注的癫痫学术领域及重点突破。本系列文章将分为五期,分别对大会每日的精彩内容进行荟萃报道:本文对大会第一日学术议程的内容进行了整理汇总,重点内容包括癫痫及癫痫持续状态药物治疗进展,癫痫认知相关共病,额叶癫痫,癫痫靶向治疗等。

    Release date:2024-03-07 01:49 Export PDF Favorites Scan
  • 芳香族抗癫痫药物所致严重皮肤不良反应的研究进展

    芳香族抗癫痫药物(AEDs)所致皮肤不良反应在临床治疗过程中较为常见,其中严重皮肤不良反应可对患者的生命造成致死性威胁。现主要对芳香族AEDs所致严重皮肤不良反应的临床表现、可能机制及治疗方法等方面的研究进行综述,从而进一步指导合理用药避免其不良反应的发生。

    Release date:2017-07-26 04:06 Export PDF Favorites Scan
  • 儿童失神癫痫药物治疗预后的研究进展

    儿童失神癫痫(Childhood absence epilepsy,CAE)是由多种遗传病因引起的最常见的特发性全面性非惊厥性癫痫,与 CAE 预后相关的因素众多,但目前尚未有确切共识的指南供临床参考,本文对 CAE 患儿药物治疗、预后情况和预后影响因素作一综述,以期能为 CAE 患儿临床的诊疗实践提供一定的参考和意见。

    Release date:2021-12-30 06:08 Export PDF Favorites Scan
  • High anxiety level and the underlying reason of people with epilepsy during the outbreak of 2019 Novel Coronavirus Diseases

    ObjectiveTo investigate the anxious level of people with epilepsy (PWE) during the outbreak of 2019 Novel Coronavirus Diseases (COVID-19) and explore the reasons of anxiety.MethodsAn internet questionnaire survey were conducted on the anxiety state of PWE and health controls (HC) aged 18 to 45 years old between Feb 9, 2020 and Feb 17, 2020. The questionnaire included demographic information, general status and the State-Trait Anxiety Inventory (STAI).ResultsIn all, 148 PWE and 300 HC were included in this study. The total SAI score (46.72±9.98 vs. 41.77±10.20, P<0.001) and the total TAI score (44.18±8.88 vs. 31.27±17.44, P<0.001) were significantly higher in PWE than in HC. PWE concerned most (69.9%) about the difficulty of obtaining antiepileptic drugs (AEDs) while HC concerned most about the lack of face masks (73.3%).ConclusionHigh anxious level in PWE during the outbreak of COVID is probably due to the difficulty of obtaining AEDs. Thus, the society should strengthen the solution of the problem of purchasing AEDs and conduct timely psychological counseling.

    Release date:2020-05-19 01:07 Export PDF Favorites Scan
  • 育龄期女性癫痫患者丙戊酸的选择策略

    鉴于丙戊酸(Valproate, VPA)宫内暴露的致畸风险及其对胎儿生长发育的影响, 2014年10月隶属于欧洲药品管理局(European Medicines Agency, EMA)的相互认证和分布处理协调小组(Coordination Group for Mutual Recognition and Decentralised Procedures-Human, CMDh)建议加强对女性使用VPA的限制, 随后国际抗癫痫联盟欧洲事务委员会(Commission on European Affairs of the International League Against Epilepsy, CEA-ILAE)及欧洲神经病学学会(European Academy of Neurology, EAN)组成的工作小组在《Epilepsia》上撰文, 旨在对育龄期女性使用VPA做出指导。撰文时, 工作小组充分考虑了使用VPA与其它替代药物的致畸风险、控制癫痫发作的重要性、癫痫发作对患者及胎儿的危害、VPA及其它抗癫痫药物对癫痫控制效力等因素。最终的建议包括以下7点:①育龄期女性应尽量避免使用VPA; ②应在医生及患者(必要时患者代理人)共同商议后决定治疗方案, 依据癫痫类型及发作形式选择合理的治疗方案时, 应仔细进行风险-获益评估; ③对于最适合VPA治疗的发作类型及综合征, 应该充分向患者及家属解释VPA及其它替代药物的获益和潜在风险; ④VPA不应作为局灶性癫痫的一线治疗药物; ⑤VPA或许可以作为治疗某些癫痫综合征的一线用药, 如特发性(遗传性)全面性癫痫伴有强直阵挛发作; ⑥VPA或许可作为生育可能性极小的女性癫痫患者的一线用药, 如合并严重的智力或身体残疾; ⑦应持续随访服用VPA的育龄期女性患者, 以确定最佳治疗方案

    Release date: Export PDF Favorites Scan
  • The effect of medication withdraw on long-term electroencephalogram monitoring in children who need preoperative assessment for refractory epilepsy

    PurposeTo analyze the effect of medication withdraw (MW) on long-term electroencephalogram (EEG) monitoring in children who need preoperative assessment for refractory epilepsy.MethodsRetrospective analysis was performed on the data of preoperative long-term EEG monitoring of children with refractory epilepsy who needed preoperative evaluation in the Pediatric Epilepsy Center of Peking University First Hospital from August 2018 to December 2019. Monitoring duration: at least three habitual seizures were detected, or the monitoring duration were as long as 10 days. MW protocol was according to the established plan.ResultsA total of 576 children (median age 4.4 years) required presurgical ictal EEGs, and 75 (75/576, 13.0%) needed MW for ictal EEGs. Among the 75 cases, 38 were male and 37 were female. The age range was from 15 months to 17 years (median age: 7.0 years). EEG and clinical data of with 65 children who strictly obey the MW protocol were analyzed. The total monitoring duration range was from 44.1 h (about 2 days) to 241.8 h (about 10 days)(median: 118.9 h (about 5 days)). Interictal EEG features before MW were including focal interictal epileptiform discharge (IED) in 39 cases (39/65, 60%), focal and generalized IED in 2 cases (2/65, 3.1%), multifocal IED in 20 cases (20/65, 30.7%), multifocal and generalized IED in 2 cases (2/65, 3.1%), and no IED in 2 cases (2/65, 3.1%). After MW, 18 cases (18/65, 27.7%) had no change in IED and the other 47 cases had changes of IED after MW. And IEDs in 46 cases (46/65, 70.8%) were aggravated, and IED was decreased in 1 case. The pattern of aggravated IED was original IED increasement, in 41 cases (41/46, 89.1%), and 5 cases (5 /46, 10.9%) had generalized IED which was not detected before MW. Of the 46 patients with IED exacerbations, 87.3% appeared within 3 days after MW. Habitual seizures were detected in 56 cases (86.2%, 56/65) after MW, and within 3 days of MW in 80.4% cases. Eight patients (14.3%) had secondary bilateral-tonic seizure (BTCS), of which only 1 patient had no BTCS in his habitual seizures. In 56 cases, 94.6% (53/56) had seizures after MW of two kinds of AEDs.Conclusions① In this group, thirteen percent children with intractable epilepsy needed MW to obtain ictal EEG; ② Most of them (86.2%) could obtain ictal EEG by MW. The IED and ictal EEG after MW were still helpful for localization of epileptogenic zone; ③ Most of the patients can obtain ictal EEG within 3 days after MW or after MW of two kinds of AEDs;4. The new secondary generalization was extremely rare.

    Release date:2021-04-25 09:50 Export PDF Favorites Scan
  • Analysis of the factors of recurrence after discontinuation of antiepileptic drugs in the first year in children with idiopathic epilepsy

    ObjectiveTo observe the children with idiopathic epilepsy who received AED therapy and seizure-free, withdrawal at least 1 year, and analyze the risk factors of seizure recurrence. In order to give better instructions for AED withdrawal of children with idiopathic epilepsy in pediatric department. MethodsChildren with idiopathic epilepsy who were seizure-free and had stopped AED treatment at least 1 year before the deadline of observation were collected from pediatric outpatient and inpatient department of the First Affiliated Hospital of Guangxi Medical University from January 2011 to January 2014. The following variables, derived from the case records were analyzed: sex, age at seizure onset, type of seizure, time period between the onset of the first seizure and start of treatment, number of seizures in the time period between the start of AED therapy and the last seizure, number of AEDs before remission, time period between the start of AED therapy and the last seizure, time period between the last seizure and withdrawal of AED treatment (seizure-free period, timing of AED withdrawal), time period between the start of AED withdrawal and total discontinuation(speed of withdrawal), EEG registered at the time of diagnosis, before AED withdrawal, during and after AED withdrawal, and the condition of recurrence, data analysed by multi-variate step-wise Cox regression model analysis. ResultsA total of 16(12.8%) children relapsed in a total number of 125 children with idiopathic epilepsy we collected; date evaluated by multi-variable analysis showed that the children suffering from seizure type of focal seizure, starting withdrawal after a seizure-free period of less than 3 years and with abnormal post-withdrawal EEG recording was associated with a higher risk of seizure recurrence. ConclusionsChildren with idiopathic epilepsy have a low risk of recurrence after AED withdrawal. Those who suffer from seizure type of focal seizure, start withdrawal after a seizure-free period of less than 3 years and with abnormal post-withdrawal EEG recording are associated with a higher risk of seizure recurrence.

    Release date: Export PDF Favorites Scan
  • 癫痫与抗癫痫药物影响男性生殖功能作用机制的研究进展

    随着国家三孩政策的开放,有生育需求的男性越来越多,越来越注重生殖健康。长期以来,癫痫患者生殖健康的关注主要在女性群体中,而对于男性癫痫患者生殖健康的研究较少。但据流行病学统计,男性癫痫患者多于女性。此外,有研究发现癫痫本身与抗癫痫药物对男性生殖功能均会产生不利影响。本文对癫痫本身与抗癫痫药物对男性癫痫患者生殖功能产生不利影响的作用机制作一综述。

    Release date:2022-02-24 02:04 Export PDF Favorites Scan
  • Ⅲ期临床试验非盲延期阶段联合使用吡仑帕奈的局灶性癫痫患者的四年药物安全性、耐受性及发作结局:307 号研究

    评估 307 号研究(临床试验验证码:NCT00735397)Ⅲ期非盲延期阶段(OLEx)联合使用吡仑帕奈的局灶性癫痫患者的药物安全性、耐受性及痫性发作结局。患者在完成任一 III 期双盲试验后均可进入非盲延期阶段(Open-labelextension,OLEx)。对所有 OLEx 队列中有同样最小吡伦帕奈暴露剂量的局灶性癫痫和继发全面性癫痫(Secondarily generalized seizures,SGS)的患者进行药物安全性及耐受性和痫性发作结局(每 28 d 中位痫性发作减少率、反应率和无发作率)的分析。另外,针对 OLEx 的早期失访进行了额外的敏感性分析。从 1 480 例双盲试验中随机分组的患者共纳入 1 218 例。大部分患者(65.4%~80.9%)仅用吡仑帕奈 12 mg,每日一次,进行治疗,并在相同剂量下完成长期的检测,或是相对基线联合使用少量抗癫痫药物(AEDs)。长期的药物安全性及耐受性结果与双盲研究一致。导致超过 1% 的患者研究中断治疗的紧急不良反应事件(Treatment-emergent adverse events,TEAEs)包括眩晕、易激、疲劳。有临床意义的 TEAEs 稳定期为 4 年。所有队列中患者的痫性发作结局随时间持续改善。对于接受 3 年(n = 436)、4 年(n = 78)药物治疗的患者 28 d 中位痫性发作减少率分别为 62%、70.6%,相应的 50% 反应率为 59.6%、67.9%。最大 28 d 中位痫性发作减少率发生于基线水平的 SGS 患者,接受 3 年(n = 190)、4 年(n = 28)药物治疗分别为 88.0% 和 100.0%。在这些队列中分别有 40.0% 和 53.6% 的患者达到了无 SGS。排除早期失访后的 28 d 中位痫性发作减少率结果类似。长期吡仑帕奈联合用药(≤4 年)不会导致新的药物安全性及耐受性问题,并且可以很大程度地减少痫性发作,特别是基线水平的 SGS 患者。

    Release date:2020-03-20 08:06 Export PDF Favorites Scan
  • 基于文献回顾及临床经验的欧洲专家意见:丙戊酸在女童和育龄期女性癫痫患者中的使用意见

    丙戊酸(Valproate,VPA)是一种广谱抗癫痫药物(Antiepileptic drugs,AEDs),相较于其他 AEDs,其对儿童癫痫综合征和特发性全面性癫痫(Idiopathic generalized epilepsy,IGE)更为有效。2018 年,欧洲药品管理局(European Medicines Agency,EMA)就 VPA 在女童和育龄期女性中的使用颁布了全新的限制条例,以避免患者在妊娠期间暴露于 VPA。此次对现有限制条例的进一步加强在患者和医学界中引发了广泛的争议和讨论。在育龄期女性中,仍有很大比例的癫痫综合征患者在使用 VPA,此外,VPA 替代药物的致畸信息缺乏,均为如何管理此类患者带来了不确定性。在本意见声明中,欧洲癫痫专家组基于文献回顾和临床经验,提出了针对不同癫痫类型的女童、育龄期女性和孕妇 AEDs 治疗的综合建议。

    Release date:2021-04-25 09:50 Export PDF Favorites Scan
4 pages Previous 1 2 3 4 Next

Format

Content